Search

Your search keyword '"Müller, Daniel J."' showing total 2,066 results

Search Constraints

Start Over You searched for: Author "Müller, Daniel J." Remove constraint Author: "Müller, Daniel J."
2,066 results on '"Müller, Daniel J."'

Search Results

4. Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression study

7. Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies

10. A primer on the use of machine learning to distil knowledge from data in biological psychiatry

16. Author Correction: Highly specific and non-invasive imaging of Piezo1-dependent activity across scales using GenEPi

17. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

21. Gray matter volume drives the brain age gap in schizophrenia: a SHAP study

27. Guía internacional para una dosificación más segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la proteína C reactiva y los niveles de clozapina

30. Liver enzyme CYP2D6 gene and tardive dyskinesia

31. Rasterkraftmikroskopie

32. Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study

34. Alterations in the neural correlates of affective inhibitory control following cognitive behavioral therapy for depression: A Canadian biomarker integration network for depression (CAN-BIND) study

35. Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment

37. Correction: Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.

39. Identifying the Common Genetic Basis of Antidepressant Response

43. Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study

44. Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

47. Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Catalog

Books, media, physical & digital resources